Health Condition 1: L210- Seborrhea capitis
Conditions
Interventions
None listed
Sponsors
Central council for Research in Ayurveda Sciences
Eligibility
Inclusion criteria
Inclusion criteria: 1. Subjects in General good health of either sex. (Subjects without other specific health complaints.) 2. Subjects within the age group of 18-55 years. 3. Subjects willing to give a written informed consent and willing to abide by and comply with the study protocol. 4. Subject exhibiting a slight to moderate dandruff or Seborrheic dermatitis of scalp on the total adherent and non adherent score after clinical examination, on Day 0. 5. Subject having stopped any possible antidandruff treatment at least 2 weeks prior to Day 0.
Exclusion criteria
Exclusion criteria: 1. Associated with other dermatological conditions such as psoriasis etc. Other Systemic illness. 2. Pregnant, lactating mothers, menopausal women. 3. Any Immuno-compromised patients and uncontrolled Diabetes 4. Systemic treatment with corticosteroids, antibiotics, immune-suppressants etc, or any modern treatment within 3 months before of this trial. 5. Subjects who have undergone hair growth treatment within 3 months before screening into the study. Subjects, who have history of alcoholism, smoking, crash dieting and/or psychiatric disorder including trichotillomania. Subjects who have had hair transplantation, who have taken pharmaceutical product which cause hirsutism(ex.phenytoin) and finasteride for androgenic alopecia, under medical treatment for hair problems. 6. A known history or present condition of allergic response/hypersensitivity to any cosmetic ingredients and pharmaceutical products. 7. Subjects on oral medications, undergoing any chemical hair salon treatmentstraightening / perming / colour / henna which will compromise the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To determine the absence or no visibility of dandruff flakes in comparison to the baseline. 2.3.2. To determine the percentage reduction in dandruff level in comparison to baseline.Timepoint: 0 day 1 week 2 weeks 4 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| To evaluate the drug acceptance, safety & toleranceTimepoint: 0 day 1 week 2 weeks 4 weeks | — |
Countries
India
Contacts
Public ContactMetuku Shantiswaroop
Anantha Laxmi Govt.Ayurvedic College
Outcome results
None listed